Literature DB >> 16840309

Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein.

Cheng Huang1, Naoto Ito, Chien-Te K Tseng, Shinji Makino.   

Abstract

Severe acute respiratory syndrome coronavirus (SCoV) 7a protein is one of the viral accessory proteins. In expressing cells, 7a protein exhibits a variety of biological activities, including induction of apoptosis, activation of the mitogen-activated protein kinase signaling pathway, inhibition of host protein translation, and suppression of cell growth progression. Analysis of SCoV particles that were purified by either sucrose gradient equilibrium centrifugation or a virus capture assay, in which intact SCoV particles were specifically immunoprecipitated by anti-S protein monoclonal antibody, demonstrated that 7a protein was associated with purified SCoV particles. Coexpression of 7a protein with SCoV S, M, N, and E proteins resulted in production of virus-like particles (VLPs) carrying 7a protein, while 7a protein was not released from cells expressing 7a protein alone. Although interaction between 7a protein and another SCoV accessory protein, 3a, has been reported, 3a protein was dispensable for assembly of 7a protein into VLPs. S protein was not required for the 7a protein incorporation into VLPs, and yet 7a protein interacted with S protein in coexpressing cells. These data established that, in addition to 3a protein, 7a protein was a SCoV accessory protein identified as a SCoV structural protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840309      PMCID: PMC1563709          DOI: 10.1128/JVI.00414-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

3.  Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells.

Authors:  J Maeda; A Maeda; S Makino
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

4.  Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal.

Authors:  Krishna Narayanan; Chun-Jen Chen; Junko Maeda; Shinji Makino
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells.

Authors:  Sangeeta Banerjee; Krishna Narayanan; Tetsuya Mizutani; Shinji Makino
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus.

Authors:  Burtram C Fielding; Yee-Joo Tan; Shen Shuo; Timothy H P Tan; Eng-Eong Ooi; Seng Gee Lim; Wanjin Hong; Phuay-Yee Goh
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence.

Authors:  Javier Ortego; Isabel Sola; Fernando Almazán; Juan E Ceriani; Cristina Riquelme; Monica Balasch; Juan Plana; Luis Enjuanes
Journal:  Virology       Date:  2003-03-30       Impact factor: 3.616

8.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

9.  The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host.

Authors:  Cornelis A M de Haan; Paul S Masters; Xiaolan Shen; Susan Weiss; Peter J M Rottier
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

10.  Murine coronavirus-induced apoptosis in 17Cl-1 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and bid cleavage.

Authors:  Chun-Jen Chen; Shinji Makino
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

View more
  53 in total

Review 1.  Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.

Authors:  Matthew Frieman; Ralph Baric
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

2.  The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex.

Authors:  Scott R Schaecher; Michael S Diamond; Andrew Pekosz
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

3.  SARS coronavirus protein 7a interacts with human Ap4A-hydrolase.

Authors:  Natalia Vasilenko; Igor Moshynskyy; Alexander Zakhartchouk
Journal:  Virol J       Date:  2010-02-09       Impact factor: 4.099

4.  Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.

Authors:  Dale L Barnard; Yohichi Kumaki
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

5.  A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.

Authors:  Corrin E McBride; Carolyn E Machamer
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

6.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.

Authors:  Monique Oostra; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

8.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

9.  Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.

Authors:  Marta L Dediego; Lecia Pewe; Enrique Alvarez; Maria Teresa Rejas; Stanley Perlman; Luis Enjuanes
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

Review 10.  SARS coronavirus accessory proteins.

Authors:  Krishna Narayanan; Cheng Huang; Shinji Makino
Journal:  Virus Res       Date:  2007-11-28       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.